HKEX Stock Code: 01093English|繁體|简体

For 2021 Annual Results

  • Sales of approximately RMB27,867 million, representing a 11.7% growth year-on-year;
  • Profit attributable to shareholders of approximately RMB5,605 million, representing a 8.6% growth year-on-year.

Highlight - 9M2022

Revenue
RMB23,496mn, +13.8%
Underlying profit attributable to shareholders
RMB4,624mn, +14.5%
Profit attributable to shareholders
RMB4,468mn, +3.1%
Basic earnings per share
RMB37.49 cents, +3.4%

Corporate Governance

Corporate Governance

Financial Calendar

Nov
23
Nov
23
Aug
24
Aug
24
May
26
Mar
22
Mar
22

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2023 CSPC Pharmaceutical Group Limited. All Rights Reserved.